Multiple sclerosis is the most common disabling neurological disease of young adults. The ability to impact the quality of life of patients with multiple sclerosis should not only incorporate therapies that are disease modifying, but should also include a course of action for the global multidisciplinary management focused on quality of life and functional capabilities.
Keywords: fatigue; multiple sclerosis; neurogenic bowel and bladder; spasticity; symptomatic therapy; visual symptoms.